Literature DB >> 17160702

Animal models relevant to schizophrenia and autism: validity and limitations.

Sylvie Tordjman1, Dominique Drapier, Olivier Bonnot, Rozenn Graignic, Sylvia Fortes, David Cohen, Bruno Millet, Claudine Laurent, Pierre L Roubertoux.   

Abstract

Development of animal models is a crucial issue in biological psychiatry. Animal models provide the opportunity to decipher the relationships between the nervous system and behavior and they are an obligatory step for drug tests. Mouse models or rat models to a lesser extent could help to test for the implication of a gene using gene targeting or transfecting technologies. One of the main problem for the development of animal models is to define a marker of the psychiatric disorder. Several markers have been suggested for schizophrenia and autism, but for the moment no markers or etiopathogenic mechanisms have been identified for these disorders. We examined here animal models related to schizophrenia and autism and discussed their validity and limitations after first defining these two disorders and considering their similarities and differences. Animal models reviewed in this article test mainly behavioral dimensions or biological mechanisms related to autistic disorder or schizophrenia rather than providing specific categorical models of autism or schizophrenia. Furthermore, most of these studies focus on a behavioral dimension associated with an underlying biological mechanism, which does not correspond to the complexity of mental disorders. It could be useful to develop animal models relevant to schizophrenia or autism to test a behavioral profile associated with a biological profile. A multi-trait approach seems necessary to better understand multidimensional disorders such as schizophrenia and autism and their biological and clinical heterogeneity. Finally, animal models can help us to clarify complex mechanisms and to study relationships between biological and behavioral variables and their interactions with environmental factors. The main interest of animal models is to generate new pertinent hypotheses relevant to humans opening the path to innovative research.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17160702     DOI: 10.1007/s10519-006-9120-5

Source DB:  PubMed          Journal:  Behav Genet        ISSN: 0001-8244            Impact factor:   2.805


  47 in total

Review 1.  Advances in nonhuman primate models of autism: Integrating neuroscience and behavior.

Authors:  M D Bauman; C M Schumann
Journal:  Exp Neurol       Date:  2017-08-01       Impact factor: 5.330

Review 2.  Brain-derived neurotrophic factor and neuropsychiatric disorders.

Authors:  Anita E Autry; Lisa M Monteggia
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

3.  Abnormal modulation of corticospinal excitability in adults with Asperger's syndrome.

Authors:  Lindsay Oberman; Mark Eldaief; Shirley Fecteau; Fritz Ifert-Miller; Jose Maria Tormos; Alvaro Pascual-Leone
Journal:  Eur J Neurosci       Date:  2012-06-28       Impact factor: 3.386

4.  Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism.

Authors:  Natalia V Malkova; Collin Z Yu; Elaine Y Hsiao; Marlyn J Moore; Paul H Patterson
Journal:  Brain Behav Immun       Date:  2012-01-30       Impact factor: 7.217

Review 5.  Use of transcranial magnetic stimulation in autism spectrum disorders.

Authors:  Lindsay M Oberman; Alexander Rotenberg; Alvaro Pascual-Leone
Journal:  J Autism Dev Disord       Date:  2015-02

Review 6.  The utility of behavioral economics in expanding the free-feed model of obesity.

Authors:  Erin B Rasmussen; Stephen H Robertson; Luis R Rodriguez
Journal:  Behav Processes       Date:  2016-02-23       Impact factor: 1.777

7.  Chronic metals ingestion by prairie voles produces sex-specific deficits in social behavior: an animal model of autism.

Authors:  J Thomas Curtis; Amber N Hood; Yue Chen; George P Cobb; David R Wallace
Journal:  Behav Brain Res       Date:  2010-04-28       Impact factor: 3.332

Review 8.  Advances in reprogramming-based study of neurologic disorders.

Authors:  Anjana Nityanandam; Kristin K Baldwin
Journal:  Stem Cells Dev       Date:  2015-04-06       Impact factor: 3.272

Review 9.  The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes.

Authors:  Valentin K Gribkoff; Leonard K Kaczmarek
Journal:  Neuropharmacology       Date:  2016-03-12       Impact factor: 5.250

10.  Interaction between environmental and genetic factors modulates schizophrenic endophenotypes in the Snap-25 mouse mutant blind-drunk.

Authors:  Peter L Oliver; Kay E Davies
Journal:  Hum Mol Genet       Date:  2009-09-03       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.